SPGI vs TERN · P/E 27, rev $15.34B vs $6.12B cap
S&P Global Inc (SPGI) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
SPGI currently screens at market cap $127.50B and trailing P/E 27.2. TERN currently screens at market cap $6.12B.
Not investment advice. Open the SPGI and TERN stock pages for the full models.
Not investment advice.